Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for Lisata Therapeutics (LSTA) over the last 13 years, with Q3 2025 value amounting to $44000.0.

  • Lisata Therapeutics' Depreciation & Amortization (CF) rose 476.19% to $44000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $198000.0, marking a year-over-year increase of 366.49%. This contributed to the annual value of $200000.0 for FY2024, which is 0.0% changed from last year.
  • As of Q3 2025, Lisata Therapeutics' Depreciation & Amortization (CF) stood at $44000.0, which was up 476.19% from $44000.0 recorded in Q2 2025.
  • Over the past 5 years, Lisata Therapeutics' Depreciation & Amortization (CF) peaked at $67000.0 during Q4 2024, and registered a low of $42000.0 during Q3 2024.
  • Over the past 3 years, Lisata Therapeutics' median Depreciation & Amortization (CF) value was $46000.0 (recorded in 2024), while the average stood at $48272.7.
  • Data for Lisata Therapeutics' Depreciation & Amortization (CF) shows a peak YoY increase of 1551.72% (in 2024) and a maximum YoY decrease of 1063.83% (in 2024) over the last 5 years.
  • Over the past 3 years, Lisata Therapeutics' Depreciation & Amortization (CF) (Quarter) stood at $58000.0 in 2023, then grew by 15.52% to $67000.0 in 2024, then crashed by 34.33% to $44000.0 in 2025.
  • Its last three reported values are $44000.0 in Q3 2025, $44000.0 for Q2 2025, and $43000.0 during Q1 2025.